Cohen, H;
Hunt, B;
Efythymiou, M;
Arachchillage, D;
Ruiz, M;
Clawson, S;
Muirhead, N;
... Collaborators, RAPST; + view all
(2015)
Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Journal of Thrombosis and Haemostasis
, 13
, Article LB003. DOI: 10.1111/jth.12993.
Preview |
Text
Cohen_1463884_RAPS_protocol_paper_V2.0_26Feb2015 - Appendices(red).pdf Download (424kB) | Preview |
| Type: | Article |
|---|---|
| Title: | Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | DOI: 10.1111/jth.12993 |
| Publisher version: | http://dx.doi.org/10.1111/jth.12993 |
| Language: | English |
| Additional information: | Special Issue: Abstracts of the XXV Congress of the International Society on Thrombosis and Haemostasis, June 20–25, 2015. This is the peer reviewed version of the following article: Cohen, H; Hunt, B; Efythymiou, M; Arachchillage, D; Ruiz, M; Clawson, S; Muirhead, N; (2015) Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. Journal of Thrombosis and Haemostasis , 13 , Article LB003, which has been published in final form at http://dx.doi.org/10.1111/jth.12993. After an initial embargo period, this article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. |
| Keywords: | Antiphospholipid syndrome; systemic lupus erythematosus; venous thromboembolism; rivaroxaban; warfarin; thrombin generation |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Haematology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Department of Imaging UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Inst of Clinical Trials and Methodology > Comprehensive CTU at UCL |
| URI: | https://discovery.ucl.ac.uk/id/eprint/1463884 |
Archive Staff Only
 |
View Item |
